Zydus Lifesciences Ltd. said on Wednesday that the US Food and Drug Administration granted its underdevelopment drug Usnoflast the orphan drug designation, according to an exchange filing on Wednesday.
The FDA’s Office of Orphan Drug Products grants orphan status to support the development of…
GIPHY App Key not set. Please check settings